Filing Details

Accession Number:
0001358403-15-000080
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-10-06 06:11:23
Reporting Period:
2015-10-01
Filing Date:
2015-10-06
Accepted Time:
2015-10-06 06:11:23
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1358403 Bellicum Pharmaceuticals Inc BLCM Pharmaceutical Preparations (2834) 201450200
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1626859 J. Thomas Farrell C/O Bellicum Pharmaceuticals, Inc.
2130 W. Holcombe Blvd., Ste. 800
Houston TX 77030
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2015-10-01 2,500 $14.58 63,862 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Reporting Person on March 26, 2015.
  2. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.2841 to $15.00. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.